{"id":"https://openalex.org/W2883375285","doi":"https://doi.org/10.1136/annrheumdis-2018-eular.5711","title":"FRI0305 Phase 2 trial of induction therapy with anti-cd20 (RITUXIMAB) followed by maintenance therapy with anti-baff (BELIMUMAB) in patients with active lupus nephritis","display_name":"FRI0305 Phase 2 trial of induction therapy with anti-cd20 (RITUXIMAB) followed by maintenance therapy with anti-baff (BELIMUMAB) in patients with active lupus nephritis","publication_year":2018,"publication_date":"2018-06-01","ids":{"openalex":"https://openalex.org/W2883375285","doi":"https://doi.org/10.1136/annrheumdis-2018-eular.5711","mag":"2883375285"},"language":"en","primary_location":{"id":"doi:10.1136/annrheumdis-2018-eular.5711","doi":"https://doi.org/10.1136/annrheumdis-2018-eular.5711","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2018-eular.5711","pdf_url":"https://ard.bmj.com/content/annrheumdis/77/Suppl_2/690.1.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ard.bmj.com/content/annrheumdis/77/Suppl_2/690.1.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015927371","display_name":"Cynthia B. Aranow","orcid":"https://orcid.org/0000-0001-9299-0053","observed_orcids":["https://orcid.org/0000-0001-9299-0053"]},"institutions":[{"id":"https://openalex.org/I1327576362","display_name":"Feinstein Institute for Medical Research","ror":"https://ror.org/05dnene97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1302444339","https://openalex.org/I1327576362"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Aranow","raw_affiliation_strings":["Feinstein Institute for Medical Research, Manhasset"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Feinstein Institute for Medical Research, Manhasset","institution_ids":["https://openalex.org/I1327576362"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034127273","display_name":"Maria Dall\u2019Era","orcid":"https://orcid.org/0000-0001-7439-2316","observed_orcids":["https://orcid.org/0000-0001-7439-2316"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Dall'Era","raw_affiliation_strings":["University of California, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112526072","display_name":"Margie Byron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153694","display_name":"Rho (United States)","ror":"https://ror.org/049ba1e57","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153694"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Byron","raw_affiliation_strings":["Rho Federal Systems, Inc, Chapel Hill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rho Federal Systems, Inc, Chapel Hill","institution_ids":["https://openalex.org/I4210153694"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046612626","display_name":"Linna Ding","orcid":"https://orcid.org/0000-0001-8035-8026","observed_orcids":["https://orcid.org/0000-0001-8035-8026"]},"institutions":[{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Ding","raw_affiliation_strings":["National Institute of Allergy and Infectious Diseases, Bethesda"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute of Allergy and Infectious Diseases, Bethesda","institution_ids":["https://openalex.org/I4210134534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038677425","display_name":"Dawn Elaine Smilek","orcid":"https://orcid.org/0000-0002-8440-8702","observed_orcids":["https://orcid.org/0000-0002-8440-8702"]},"institutions":[{"id":"https://openalex.org/I4210094308","display_name":"Immune Tolerance Network","ror":"https://ror.org/00pjnm784","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210094308","https://openalex.org/I4210134534"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Smilek","raw_affiliation_strings":["Immune Tolerance Network (ITN), San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immune Tolerance Network (ITN), San Francisco, USA","institution_ids":["https://openalex.org/I4210094308"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089808423","display_name":"Betty Diamond","orcid":"https://orcid.org/0000-0002-3250-3804","observed_orcids":["https://orcid.org/0000-0002-3250-3804"]},"institutions":[{"id":"https://openalex.org/I1327576362","display_name":"Feinstein Institute for Medical Research","ror":"https://ror.org/05dnene97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1302444339","https://openalex.org/I1327576362"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Diamond","raw_affiliation_strings":["Feinstein Institute for Medical Research, Manhasset"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Feinstein Institute for Medical Research, Manhasset","institution_ids":["https://openalex.org/I1327576362"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054643514","display_name":"David Wofsy","orcid":"https://orcid.org/0000-0001-8350-3428","observed_orcids":["https://orcid.org/0000-0001-8350-3428"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Wofsy","raw_affiliation_strings":["University of California, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":19,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":null,"first_page":"690","last_page":"690"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lupus-nephritis","display_name":"lupus nephritis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.8700000047683716},{"id":"https://openalex.org/keywords/belimumab","display_name":"belimumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anti-cd20-therapy","display_name":"anti-CD20 therapy","score":0.75},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.765999972820282},{"id":"https://openalex.org/keywords/b-cell-activating-factor","display_name":"B-cell activating factor","score":0.8399999737739563},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.5440000295639038},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.6380000114440918},{"id":"https://openalex.org/keywords/partial-response","display_name":"partial response","score":0.48899999260902405},{"id":"https://openalex.org/keywords/prednisone-tapering","display_name":"prednisone tapering","score":0.5960000157356262},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.753000020980835},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.5529999732971191},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.4490000009536743},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.3659999966621399},{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.9089999794960022}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.910045862197876},{"id":"https://openalex.org/C2781205201","wikidata":"https://www.wikidata.org/wiki/Q1996249","display_name":"Belimumab","level":5,"score":0.8290300965309143},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.7558420896530151},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.6832519173622131},{"id":"https://openalex.org/C170286685","wikidata":"https://www.wikidata.org/wiki/Q409346","display_name":"B-cell activating factor","level":4,"score":0.6578125953674316},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6059966683387756},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5688918232917786},{"id":"https://openalex.org/C2779912601","wikidata":"https://www.wikidata.org/wiki/Q1621830","display_name":"Lupus nephritis","level":3,"score":0.5351613163948059},{"id":"https://openalex.org/C2780372218","wikidata":"https://www.wikidata.org/wiki/Q417222","display_name":"Methylprednisolone","level":2,"score":0.47478339076042175},{"id":"https://openalex.org/C2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","level":3,"score":0.4175068736076355},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3854345381259918},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37486714124679565},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.25261229276657104},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.15784737467765808},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.12336432933807373},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/annrheumdis-2018-eular.5711","doi":"https://doi.org/10.1136/annrheumdis-2018-eular.5711","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2018-eular.5711","pdf_url":"https://ard.bmj.com/content/annrheumdis/77/Suppl_2/690.1.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1136/annrheumdis-2018-eular.5711","doi":"https://doi.org/10.1136/annrheumdis-2018-eular.5711","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2018-eular.5711","pdf_url":"https://ard.bmj.com/content/annrheumdis/77/Suppl_2/690.1.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320335551","display_name":"Erasmus+","ror":"https://ror.org/01v2m4n16"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2883375285.pdf","grobid_xml":"https://content.openalex.org/works/W2883375285.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3022444635","https://openalex.org/W2938263158","https://openalex.org/W2052515576","https://openalex.org/W2519546432","https://openalex.org/W3047551100","https://openalex.org/W2126746651","https://openalex.org/W3013124423","https://openalex.org/W1989273660","https://openalex.org/W3037971555","https://openalex.org/W4399547262"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2018-08-03T00:00:00"}